Assisted Reproductive Technology
Assisted Reproductive Technology Market (ART) by Type (Egg or Sperm Donation, Frozen Embryo Replacement (FER), In Vitro Fertilization (IVF)), Method (Blastocyst Culture and Transfer, Conventional IVF, Cryopreservation Method), End User, Fertility Drug Type, Cycle Stage, Patient Type, Application, Technology, Device Type, Service Provider - Global Forecast 2025-2030
SKU
MRR-436901065A94
Region
Global
Publication Date
February 2025
Delivery
Immediate
2024
USD 29.52 billion
2025
USD 34.76 billion
2030
USD 78.18 billion
CAGR
17.62%

The Assisted Reproductive Technology Market size was estimated at USD 29.52 billion in 2024 and expected to reach USD 34.76 billion in 2025, at a CAGR 17.62% to reach USD 78.18 billion by 2030.

Assisted Reproductive Technology Market
To learn more about this report, request a free PDF copy

Assisted Reproductive Technology (ART) encompasses medical processes like in vitro fertilization (IVF) that aid individuals in achieving pregnancy. The necessity of ART arises from the increasing infertility rates due to factors such as delayed childbearing, lifestyle changes, and underlying medical conditions. Its applications predominantly include IVF, gamete intrafallopian transfer (GIFT), and zygote intrafallopian transfer (ZIFT), with end-use scope across fertility clinics, hospitals, and surgical centers. Key growth factors driving this market include rising awareness about infertility treatments, technological advancements in reproductive health, and supportive governmental policies and insurance coverage expansion. Recent potential opportunities lie within emerging markets with less saturated markets, namely Asia-Pacific and Latin America, due to their increasing healthcare expenditures and evolving societal norms regarding fertility treatments. Moreover, technological advancements like AI in embryology and genetic testing present lucrative avenues for market players. However, limitations include high treatment costs, ethical concerns, and lack of universal regulatory standards. Challenges such as limited access in rural areas and social stigmas associated with infertility and ART procedures also hinder growth. To harness business growth, innovations around cost-effective solutions, personalized medicine, and minimally invasive techniques are crucial. Investment in research about the long-term health impacts of ART procedures, along with development of eco-friendly embryonic culture systems, stands as a promising innovation area. The ART market is highly competitive, with strategic partnerships and acquisitions being key for players to expand their footprint. The nature of the market is dynamic, driven by continuous technological, societal, and regulatory evolutions. Organizations should focus on public awareness campaigns about the effectiveness and safety of ART, along with advocating for policies that enhance access to these reproductive technologies to sustain and expand their market presence.

Ask ResearchAI anything

World's First Innovative Al for Market Research

Ask your question about the Assisted Reproductive Technology market, and ResearchAI will deliver precise answers.
How ResearchAI Enhances the Value of Your Research
ResearchAI-as-a-Service
Gain reliable, real-time access to a responsible AI platform tailored to meet all your research requirements.
24/7/365 Accessibility
Receive quick answers anytime, anywhere, so you’re always informed.
Maximize Research Value
Gain credits to improve your findings, complemented by comprehensive post-sales support.
Multi Language Support
Use the platform in your preferred language for a more comfortable experience.
Stay Competitive
Use AI insights to boost decision-making and join the research revolution at no extra cost.
Time and Effort Savings
Simplify your research process by reducing the waiting time for analyst interactions in traditional methods.

Market Dynamics

The market dynamics represent an ever-changing landscape of the Assisted Reproductive Technology Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

  • Market Drivers
    • Growth in medical tourism offering cost-effective ART solutions for international patient populations
    • Technological innovations reducing costs and making ART more accessible to a broader audience
    • Growing global infertility rates prompting increased demand for assisted reproductive technologies
  • Market Restraints
    • Factors limiting the acceleration of advancements in assisted reproductive technologies worldwide
    • Elements restricting broader societal acceptance and application of assisted reproductive technologies
    • Key market restraints impacting the growth of the assisted reproductive technology industry
  • Market Opportunities
    • Focusing on male fertility innovations to address the rising concerns of declining sperm quality
    • Investing in cryopreservation advancements to enhance the longevity and success of stored gametes
    • Developing integrative health solutions combining fertility treatments with lifestyle improvement plans
  • Market Challenges
    • Finding effective strategies to handle privacy concerns and data security in reproductive treatments
    • Ensuring comprehensive education and support services for ART patients throughout their journey
    • Proactively dealing with increasing genetic and biological risks associated with reproductive assistance

Porter’s Five Forces Analysis

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Assisted Reproductive Technology Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

PESTLE Analysis

The PESTLE analysis offers a comprehensive tool for understanding and analyzing the external macro-environmental factors that impact businesses within the Assisted Reproductive Technology Market. This framework examines Political, Economic, Social, Technological, Legal, and Environmental factors, providing companies with insights into how these elements influence their operations and strategic decisions. By using PESTLE analysis, businesses can identify potential opportunities and threats in the market, adapt to changes in the external environment, and make informed decisions that align with current and future conditions. This analysis helps companies anticipate shifts in regulation, consumer behavior, technology, and economic conditions, allowing them to better navigate risks and capitalize on emerging trends.

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Assisted Reproductive Technology Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Assisted Reproductive Technology Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Assisted Reproductive Technology Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Assisted Reproductive Technology Market, highlighting leading vendors and their innovative profiles. These include Carl Zeiss AG, CCB Kitazato, LLC, CooperSurgical, Inc. Cooper Companies Inc., Cryolab Ltd., Esco Micro Pte. Ltd.Esco Lifesciences Group, Ferring B.V., FUJIFILM Irvine Scientific, Inc., Genea Limited, INVO Bioscience, Merck & Co., Inc., Nidacon International AB, Planer PLC by Hamilton Thorne, Inc., Rocket Medical plc by Röko AB, Thermo Fisher Scientific company, and Vitrolife AB.

Market Segmentation & Coverage

This research report categorizes the Assisted Reproductive Technology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Egg or Sperm Donation
    • Frozen Embryo Replacement (FER)
    • In Vitro Fertilization (IVF)
    • Intracytoplasmic Sperm Injection (ICSI)
  • Method
    • Blastocyst Culture and Transfer
    • Conventional IVF
    • Cryopreservation Method
    • Stimulation Protocol
  • End User
    • Clinical Research Institutes
    • Fertility Clinics
    • Hospitals
    • Research Centers
  • Fertility Drug Type
    • Aromatase Inhibitors
    • Gonadotropin-Releasing Hormone (GnRH) Agonists
    • Gonadotropins
      • Follicle Stimulating Hormones (FSH)
      • Human Menopausal Gonadotropins (hMG)
      • Luteinizing Hormones (LH)
    • Selective Estrogen Receptor Modulators (SERMs)
  • Cycle Stage
    • Egg Retrieval
    • Embryo Transfer
    • Fertilization
    • Ovarian Stimulation
  • Patient Type
    • Female Infertility
      • Endometriosis
      • Polycystic Ovary Syndrome (PCOS)
      • Premature Ovarian Failure
    • Male Infertility
      • Non-obstructive Azoospermia
      • Obstructive Azoospermia
    • Recurrent Pregnancy Loss
  • Application
    • Genetic Disorder Screening
    • Preservation of Fertile Eggs for Cancer Patients
    • Treatment of Infertility
  • Technology
    • AI and Big Data in ART
    • Cryotechnology
      • Vitrification
    • Preimplantation Genetic Testing (PGT)
    • Time-Lapse Microscopy
  • Device Type
    • Cryo Systems
    • Incubators
    • Microscopes and Imaging Systems
    • Sperm Separation Devices
  • Service Provider
    • Non-Governmental Organizations
    • Private Clinics
    • Public Facilities
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

This research report offers invaluable insights into various crucial aspects of the Assisted Reproductive Technology Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?
Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Assisted Reproductive Technology Market, by Type
  7. Assisted Reproductive Technology Market, by Method
  8. Assisted Reproductive Technology Market, by End User
  9. Assisted Reproductive Technology Market, by Fertility Drug Type
  10. Assisted Reproductive Technology Market, by Cycle Stage
  11. Assisted Reproductive Technology Market, by Patient Type
  12. Assisted Reproductive Technology Market, by Application
  13. Assisted Reproductive Technology Market, by Technology
  14. Assisted Reproductive Technology Market, by Device Type
  15. Assisted Reproductive Technology Market, by Service Provider
  16. Americas Assisted Reproductive Technology Market
  17. Asia-Pacific Assisted Reproductive Technology Market
  18. Europe, Middle East & Africa Assisted Reproductive Technology Market
  19. Competitive Landscape
  20. List of Figures [Total: 37]
  21. List of Tables [Total: 646 ]
  22. List of Companies Mentioned [Total: 15]
360iResearch Analyst Ketan Rohom
Download a Free PDF
Get a sneak peek into the valuable insights and in-depth analysis featured in our comprehensive assisted reproductive technology market report. Download now to stay ahead in the industry! Need more tailored information? Ketan is here to help you find exactly what you need.
Frequently Asked Questions
  1. How big is the Assisted Reproductive Technology Market?
    Ans. The Global Assisted Reproductive Technology Market size was estimated at USD 29.52 billion in 2024 and expected to reach USD 34.76 billion in 2025.
  2. What is the Assisted Reproductive Technology Market growth?
    Ans. The Global Assisted Reproductive Technology Market to grow USD 78.18 billion by 2030, at a CAGR of 17.62%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.